Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

United States Plasma Therapy Market Report 2021

  • QYR648269
  • 101 Pages
  • August 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Plasma Therapy

Revenue, means the sales value of Plasma Therapy

This report studies sales (consumption) of Plasma Therapy in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

BioLife Plasma Services (U.S.)

Cambryn Biologics LLC (U.S.)

Biotest (Germany)

CSL Ltd. (Australia)

Grifols International S.A. (Spain)

Kedrion S.p.A. (Italy)

LFB (France)

Bio Products Laboratory Ltd. (BPL) (U.K.)

China Biologic Products, Inc. (China)

Octapharma (Switzerland)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Pure PRP

Leukocyte-Rich PRP

Pure Platelet-Rich Fibrin

Leukocyte-Rich Fibrin

Split by applications, this report focuses on sales, market share and growth rate of Plasma Therapy in each application, can be divided into

Orthopedic

Dermatology

Cardiac Muscle Injury

Table of Contents

United States Plasma Therapy Market Report 2021

1 Plasma Therapy Overview

1.1 Product Overview and Scope of Plasma Therapy

1.2 Classification of Plasma Therapy

1.2.1 Pure PRP

1.2.2 Leukocyte-Rich PRP

1.2.3 Pure Platelet-Rich Fibrin

1.2.4 Leukocyte-Rich Fibrin

1.3 Applications of Plasma Therapy

1.3.1 Orthopedic

1.3.2 Dermatology

1.3.3 Cardiac Muscle Injury

1.4 USA Market Size (Value and Volume) of Plasma Therapy (2011-2021)

1.4.1 USA Plasma Therapy Sales, Revenue and Price (2011-2021)

1.4.2 USA Plasma Therapy Sales and Growth Rate (2011-2021)

1.4.3 USA Plasma Therapy Revenue and Growth Rate (2011-2021)

2 USA Plasma Therapy Competition by Manufacturers

2.1 USA Plasma Therapy Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Plasma Therapy Revenue and Share by Manufactures (2015 and 2016)

3 USA Plasma Therapy (Volume and Value) by Type

3.1 USA Plasma Therapy Sales and Market Share by Type (2011-2021)

3.2 USA Plasma Therapy Revenue and Market Share by Type (2011-2021)

4 USA Plasma Therapy (Volume) by Application

5 USA Plasma Therapy Manufacturers Analysis

5.1 BioLife Plasma Services (U.S.)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Plasma Therapy Product Type and Technology

5.1.2.1 Pure PRP

5.1.2.2 Leukocyte-Rich PRP

5.1.3 Plasma Therapy Sales, Revenue, Price of BioLife Plasma Services (U.S.) (2015 and 2016)

5.2 Cambryn Biologics LLC (U.S.)

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Medical Devices Product Type and Technology

5.2.2.1 Pure PRP

5.2.2.2 Leukocyte-Rich PRP

5.2.3 Medical Devices Sales, Revenue, Price of Cambryn Biologics LLC (U.S.) (2015 and 2016)

5.3 Biotest (Germany)

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Biotest (Germany) Product Type and Technology

5.3.2.1 Pure PRP

5.3.2.2 Leukocyte-Rich PRP

5.3.3 Biotest (Germany) Sales, Revenue, Price of Biotest (Germany) (2015 and 2016)

5.4 CSL Ltd. (Australia)

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 China Biologic Products, Inc. (China) Product Type and Technology

5.4.2.1 Pure PRP

5.4.2.2 Leukocyte-Rich PRP

5.4.3 CSL Ltd. (Australia) Sales, Revenue, Price of CSL Ltd. (Australia) (2015 and 2016)

5.5 Grifols International S.A. (Spain)

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Grifols International S.A. (Spain) Product Type and Technology

5.5.2.1 Pure PRP

5.5.2.2 Leukocyte-Rich PRP

5.5.3 Grifols International S.A. (Spain) Sales, Revenue, Price of Grifols International S.A. (Spain) (2015 and 2016)

5.6 Kedrion S.p.A. (Italy)

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 Kedrion S.p.A. (Italy) Product Type and Technology

5.6.2.1 Pure PRP

5.6.2.2 Leukocyte-Rich PRP

5.6.3 Kedrion S.p.A. (Italy) Sales, Revenue, Price of Kedrion S.p.A. (Italy) (2015 and 2016)

5.7 LFB (France)

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 LFB (France) Product Type and Technology

5.7.2.1 Pure PRP

5.7.2.2 Leukocyte-Rich PRP

5.7.3 LFB (France) Sales, Revenue, Price of LFB (France) (2015 and 2016)

5.8 Bio Products Laboratory Ltd. (BPL) (U.K.)

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Bio Products Laboratory Ltd. (BPL) (U.K.) Product Type and Technology

5.8.2.1 Pure PRP

5.8.2.2 Leukocyte-Rich PRP

5.8.3 Bio Products Laboratory Ltd. (BPL) (U.K.) Sales, Revenue, Price of Bio Products Laboratory Ltd. (BPL) (U.K.) (2015 and 2016)

5.9 China Biologic Products, Inc. (China)

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 China Biologic Products, Inc. (China) Product Type and Technology

5.9.2.1 Pure PRP

5.9.2.2 Leukocyte-Rich PRP

5.9.3 China Biologic Products, Inc. (China) Sales, Revenue, Price of China Biologic Products, Inc. (China) (2015 and 2016)

5.10 Octapharma (Switzerland)

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Octapharma (Switzerland) Product Type and Technology

5.10.2.1 Pure PRP

5.10.2.2 Leukocyte-Rich PRP

5.10.3 Octapharma (Switzerland) Sales, Revenue, Price of Octapharma (Switzerland) (2015 and 2016)

6 Plasma Therapy Technology and Development Trend

6.1 Plasma Therapy Technology Analysis

6.2 Plasma Therapy Technology Development Trend

7 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Plasma Therapy

Table Classification of Plasma Therapy

Figure USA Sales Market Share of Plasma Therapy by Type in 2015

Figure Pure PRP Picture

Figure Leukocyte-Rich PRP Picture

Figure Pure Platelet-Rich Fibrin Picture

Figure Leukocyte-Rich Fibrin Picture

Table Applications of Plasma Therapy

Figure USA Sales Market Share of Plasma Therapy by Application in 2015

Figure Orthopedic Examples

Figure Dermatology Examples

Figure Cardiac Muscle Injury Examples

Table USA Plasma Therapy Sales, Revenue and Price (2011-2021)

Figure USA Plasma Therapy Sales and Growth Rate (2011-2021)

Figure USA Plasma Therapy Revenue and Growth Rate (2011-2021)

Table USA Plasma Therapy Sales of Key Manufacturers (2015 and 2016)

Table USA Plasma Therapy Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Plasma Therapy Sales Share by Manufacturers

Figure 2016 Plasma Therapy Sales Share by Manufacturers

Table USA Plasma Therapy Revenue by Manufacturers (2015 and 2016)

Table USA Plasma Therapy Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Plasma Therapy Revenue Share by Manufacturers

Table 2016 USA Plasma Therapy Revenue Share by Manufacturers

Table USA Plasma Therapy Sales and Market Share by Type (2011-2021)

Table USA Plasma Therapy Sales Share by Type (2011-2021)

Figure Sales Market Share of Plasma Therapy by Type (2011-2021)

Figure USA Plasma Therapy Sales Growth Rate by Type (2011-2021)

Table USA Plasma Therapy Revenue and Market Share by Type (2011-2021)

Table USA Plasma Therapy Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Plasma Therapy by Type (2011-2021)

Figure USA Plasma Therapy Revenue Growth Rate by Type (2011-2021)

Table USA Plasma Therapy Sales and Market Share by Application (2011-2021)

Table USA Plasma Therapy Sales Share by Application (2011-2021)

Figure Sales Market Share of Plasma Therapy by Application (2011-2021)

Figure USA Plasma Therapy Sales Growth Rate by Application (2011-2021)

Table BioLife Plasma Services (U.S.) Basic Information List

Table Plasma Therapy Sales, Revenue, Price of BioLife Plasma Services (U.S.) (2015 and 2016)

Table Cambryn Biologics LLC (U.S.) Basic Information List

Table Plasma Therapy Sales, Revenue, Price of Cambryn Biologics LLC (U.S.) (2015 and 2016)

Table Biotest (Germany) Basic Information List

Table Plasma Therapy Sales, Revenue, Price of Biotest (Germany) (2015 and 2016)

Table CSL Ltd. (Australia) Basic Information List

Table Plasma Therapy Sales, Revenue, Price of CSL Ltd. (Australia) (2015 and 2016)

Table Grifols International S.A. (Spain) Basic Information List

Table Plasma Therapy Sales, Revenue, Price of Grifols International S.A. (Spain) (2015 and 2016)

Table Kedrion S.p.A. (Italy) Basic Information List

Table Plasma Therapy Sales, Revenue, Price of Kedrion S.p.A. (Italy) (2015 and 2016)

Table LFB (France) Basic Information List

Table Plasma Therapy Sales, Revenue, Price of LFB (France) (2015 and 2016)

Table Bio Products Laboratory Ltd. (BPL) (U.K.) Basic Information List

Table Plasma Therapy Sales, Revenue, Price of Bio Products Laboratory Ltd. (BPL) (U.K.) (2015 and 2016)

Table China Biologic Products, Inc. (China) Basic Information List

Table Plasma Therapy Sales, Revenue, Price of China Biologic Products, Inc. (China) (2015 and 2016)

Table Octapharma (Switzerland) Basic Information List

Table Plasma Therapy Sales, Revenue, Price of Octapharma (Switzerland) (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370